KYMR
Price
$64.82
Change
+$0.51 (+0.79%)
Updated
Nov 19 closing price
Capitalization
4.67B
91 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$17.73
Change
-$0.76 (-4.11%)
Updated
Nov 19 closing price
Capitalization
898.42M
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs TBPH

Header iconKYMR vs TBPH Comparison
Open Charts KYMR vs TBPHBanner chart's image
Kymera Therapeutics
Price$64.82
Change+$0.51 (+0.79%)
Volume$505.14K
Capitalization4.67B
Theravance Biopharma
Price$17.73
Change-$0.76 (-4.11%)
Volume$538.23K
Capitalization898.42M
KYMR vs TBPH Comparison Chart in %
KYMR
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KYMR vs. TBPH commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and TBPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (KYMR: $64.92 vs. TBPH: $17.73)
Brand notoriety: KYMR and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 64% vs. TBPH: 138%
Market capitalization -- KYMR: $4.67B vs. TBPH: $898.42M
KYMR [@Biotechnology] is valued at $4.67B. TBPH’s [@Biotechnology] market capitalization is $898.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and TBPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • TBPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KYMR and TBPH are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а +2.19% price change this week, while TBPH (@Biotechnology) price change was -0.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.67B) has a higher market cap than TBPH($898M). TBPH YTD gains are higher at: 88.417 vs. KYMR (61.372). TBPH has higher annual earnings (EBITDA): 46.1M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. TBPH (339M). TBPH has less debt than KYMR: TBPH (46.5M) vs KYMR (85.7M). TBPH has higher revenues than KYMR: TBPH (77.2M) vs KYMR (44.7M).
KYMRTBPHKYMR / TBPH
Capitalization4.67B898M520%
EBITDA-267.03M46.1M-579%
Gain YTD61.37288.41769%
P/E RatioN/A31.11-
Revenue44.7M77.2M58%
Total Cash665M339M196%
Total Debt85.7M46.5M184%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
76
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRTBPH
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 29 days ago
87%
Bearish Trend 13 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMCIX28.95N/A
N/A
BlackRock High Equity Income Instl
FAASX31.08N/A
N/A
Fidelity Advisor Asset Manager 70% A
CVLFX15.19N/A
N/A
Cullen Value C
SGICX17.43N/A
N/A
SGI US Large Cap Equity C
IARRX16.53-0.15
-0.90%
Invesco Real Estate R

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.95%
NRIX - KYMR
64%
Loosely correlated
+13.09%
VERA - KYMR
61%
Loosely correlated
-1.25%
IDYA - KYMR
54%
Loosely correlated
-1.72%
RGNX - KYMR
54%
Loosely correlated
-2.84%
NUVL - KYMR
54%
Loosely correlated
+2.71%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-4.11%
KYMR - TBPH
48%
Loosely correlated
+0.95%
VERA - TBPH
36%
Loosely correlated
-1.25%
AXON - TBPH
34%
Loosely correlated
-0.50%
VYGR - TBPH
34%
Loosely correlated
-2.69%
ARRY - TBPH
34%
Loosely correlated
-2.47%
More